UK pays 'low price' for cancer drugs
The UK is paying less for new cancer drugs than a number of other high-income countries, according to a report in The Lancet Oncology.The UK is paying less for new cancer drugs than a number of other high-income countries, according to a report in The Lancet Oncology.